There are limited epidemiologic studies describing the global burden and geographic
heterogeneity of interstitial lung disease (ILD) subtypes. We found that among seventeen …

Background The purpose of this analysis is to provide evidence-based and consensus-
derived guidance for clinicians to improve individual diagnostic decision-making for …

Idiopathic pulmonary fibrosis is a chronic fibrotic lung disease of unknown cause that occurs
in adults and has a poor prognosis. Its epidemiology has been difficult to study because of …

Rationale: Interstitial lung disease (ILD) is a heterogeneous group of acute and chronic
inflammatory and fibrotic lung diseases. Existing ILD registries have had variable findings …

In addition to facilitating healthcare delivery planning, reliable information about prognosis is
essential for treatment decisions in patients with idiopathic pulmonary fibrosis (IPF). This …

More than 100 different conditions are grouped under the term interstitial lung disease (ILD).
A diagnosis of an ILD primarily relies on a combination of clinical, radiological, and …

Rationale: Accurate diagnosis of interstitial lung disease is necessary to identify the most
appropriate management strategy and to inform prognosis. Many patients cannot be …

Background and objective The epidemiology of interstitial lung diseases (ILDs) in
developing countries remains unknown. The objective of this study was to estimate the …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and devastating disorder. It is
characterized by alveolar epithelial cell injury and activation, infiltration of inflammatory cells …

Background The spectrum of interstitial lung diseases (ILDs) have mainly been reported
from the developed countries; data from developing countries is sparse and conflicting. The …